文献速递糖尿病

邻苯二甲酸酯与中年女性新发糖尿病:全国女性健康研究(SWAN)

Phthalates and Incident Diabetes in Midlife Women: The Study of Women's Health Across the Nation (SWAN).
PubMed 文献 · J Clin Endocrinol Metab · 2023-01-01

在SWAN多种污染物研究中,随访1308名1999-2000年无糖尿病的中年女性6年,检测11种尿邻苯二甲酸酯代谢物。白人女性中部分高分子量代谢物浓度每翻倍与新发糖尿病风险升高30%-63%相关,黑人和亚裔女性中无关联。邻苯二甲酸酯是否导致糖尿病需进一步研究。

要点

  • 6年随访期间61名女性发生糖尿病,累积发病率为4.7%。
  • 白人女性中MiBP每翻倍HR=1.63(95%CI 1.18-2.25),MCNP每翻倍HR=1.30(95%CI 1.03-1.65)。
  • 黑人和亚裔女性中邻苯二甲酸酯与糖尿病发病率无关联。

核心结论

  • 部分邻苯二甲酸酯代谢物与6年内较高的糖尿病发病率相关,但关联在不同种族/民族间不一致。
  • 邻苯二甲酸酯是否导致糖尿病需进一步研究。

研究设计与样本

  • 在SWAN多种污染物研究中,随访1308名1999-2000年无糖尿病的中年女性6年。
  • 1999-2000年和2002-2003年检测点尿样中11种邻苯二甲酸酯代谢物,1999-2000年至2005-2006年确认新发糖尿病。
  • 采用时变暴露的Cox比例风险模型估计每种代谢物与糖尿病的风险比(HR),校正人口学、生活方式和健康相关因素,并用交互项检验种族/民族的效应修饰。

主要发现

  • 6年随访期间61名女性发生糖尿病,累积发病率为4.7%。
  • 全体女性中,几种高分子量邻苯二甲酸酯代谢物与较高的糖尿病发病率相关,但均无统计学显著性。
  • 白人女性中,邻苯二甲酸单异丁酯(MiBP)、邻苯二甲酸单苄酯、邻苯二甲酸单羧基辛酯、邻苯二甲酸单羧基异壬酯(MCNP)和邻苯二甲酸单(3-羧基丙基)酯浓度每翻倍与糖尿病发病率升高30%至63%相关(MCNP:HR=1.30,95%CI 1.03-1.65;MiBP:HR=1.63,95%CI 1.18-2.25)。
  • 黑人或亚裔女性中,邻苯二甲酸酯与糖尿病发病率无关联。

关键数值与推荐

  • 白人女性中MiBP每翻倍HR=1.63(95%CI 1.18-2.25),MCNP每翻倍HR=1.30(95%CI 1.03-1.65)。
  • 6年随访累积糖尿病发病率为4.7%(61/1308)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Phthalates are hypothesized to contribute to diabetes, but longitudinal evidence in humans is limited. OBJECTIVE: We examined whether phthalate exposure was associated with a higher incidence of diabetes in a racially/ethnically diverse cohort of midlife women. METHODS: In the Study of Women's Health Across the Nation Multipollutant Study, we followed 1308 women without diabetes in 1999-2000 for 6 years. Eleven phthalate metabolites were measured in spot urine samples in 1999-2000 and 2002-2003. Incident diabetes was ascertained between 1999-2000 and 2005-2006. Cox proportional hazards models with time-varying exposure were used to estimate the hazard ratio (HR) of diabetes associated with each phthalate metabolite, adjusting for demographic, lifestyle, and health-related factors. Effect modification by race/ethnicity was examined with interaction terms. RESULTS: Sixty-one women developed diabetes over 6 years (cumulative incidence = 4.7%). Among all women, several high-molecular-weight phthalate metabolites were associated with a higher incidence of diabetes, but none were statistically significant. There was effect modification by race/ethnicity. Among White women, each doubling of the concentrations of mono-isobutyl phthalate (MiBP), monobenzyl phthalate, mono-carboxyoctyl phthalate, mono-carboxyisononyl phthalate (MCNP), and mono(3-carboxypropyl) phthalate was associated with a 30% to 63% higher incidence of diabetes (HR = 1.30, 95% CI, 1.03-1.65 for MCNP; HR = 1.63, 95% CI, 1.18-2.25 for MiBP). In contrast, phthalates were not associated with diabetes incidence in Black or Asian women. CONCLUSIONS: Some phthalate metabolites were associated with a higher incidence of diabetes over 6 years, but the associations were inconsistent across racial/ethnic groups. Whether phthalates cause diabetes requires further investigation.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Peng MQ, Karvonen-Gutierrez CA, Herman WH, et al. Phthalates and Incident Diabetes in Midlife Women: The Study of Women's Health Across the Nation (SWAN). J Clin Endocrinol Metab. 2023. PMID: 36752637. doi:10.1210/clinem/dgad033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。